Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection

Martin R Jakobsen; Kieran Cashin; Michael Roche; Jasminka Sterjovski; Anne Ellett; Katharina Borm; Jacqueline Flynn; Christian Erikstrup; Maelenn Gouillou; Lachlan R Gray; Nitin K Saksena; Bin Wang; Damian F J Purcell; Per Kallestrup; Rutendo B Zinyama-Gutsire; Exnevia Gomo; Henrik Ullum; Lars Ostergaard; Benhur Lee; Paul A Ramsland; Melissa J Churchill; Paul R Gorry

doi:10.1371/journal.pone.0065950

Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection

Martin R Jakobsen, Kieran Cashin, Michael Roche, Jasminka Sterjovski, Anne Ellett, Katharina Borm, Jacqueline Flynn, Christian Erikstrup, Maelenn Gouillou, Lachlan R Gray, Nitin K Saksena, Bin Wang, Damian F J Purcell, Per Kallestrup, Rutendo B Zinyama-Gutsire, Exnevia Gomo, Henrik Ullum, Lars Ostergaard, Benhur Lee, Paul A RamslandMelissa J Churchill, Paul R Gorry

24 Citations (Scopus)

Abstract

HIV-1 subtype C (C-HIV) is responsible for most HIV-1 cases worldwide. Although the pathogenesis of C-HIV is thought to predominantly involve CCR5-restricted (R5) strains, we do not have a firm understanding of how frequently CXCR4-using (X4 and R5X4) variants emerge in subjects with progressive C-HIV infection. Nor do we completely understand the molecular determinants of coreceptor switching by C-HIV variants. Here, we characterized a panel of HIV-1 envelope glycoproteins (Envs) (n = 300) cloned sequentially from plasma of 21 antiretroviral therapy (ART)-naïve subjects who experienced progression from chronic to advanced stages of C-HIV infection, and show that CXCR4-using C-HIV variants emerged in only one individual. Mutagenesis studies and structural models suggest that the evolution of R5 to X4 variants in this subject principally involved acquisition of an "Ile-Gly" insertion in the gp120 V3 loop and replacement of the V3 "Gly-Pro-Gly" crown with a "Gly-Arg-Gly" motif, but that the accumulation of additional gp120 "scaffold" mutations was required for these V3 loop changes to confer functional effects. In this context, either of the V3 loop changes could confer possible transitional R5X4 phenotypes, but when present together they completely abolished CCR5 usage and conferred the X4 phenotype. Our results show that the emergence of CXCR4-using strains is rare in this cohort of untreated individuals with advanced C-HIV infection. In the subject where X4 variants did emerge, alterations in the gp120 V3 loop were necessary but not sufficient to confer CXCR4 usage.

Original language	English
Journal	PLOS ONE
Volume	8
Issue number	6
Pages (from-to)	e65950
ISSN	1932-6203
DOIs	https://doi.org/10.1371/journal.pone.0065950
Publication status	Published - 18 Jun 2013

Keywords

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1371/journal.pone.0065950

journal.pone.0065950&type=printableFinal published version, 2.16 MBLicence: CC BY

Cite this

Jakobsen, M. R., Cashin, K., Roche, M., Sterjovski, J., Ellett, A., Borm, K., Flynn, J., Erikstrup, C., Gouillou, M., Gray, L. R., Saksena, N. K., Wang, B., Purcell, D. F. J., Kallestrup, P., Zinyama-Gutsire, R. B., Gomo, E., Ullum, H., Ostergaard, L., Lee, B., ... Gorry, P. R. (2013). Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection. PLOS ONE, 8(6), e65950. https://doi.org/10.1371/journal.pone.0065950

Jakobsen, MR, Cashin, K, Roche, M, Sterjovski, J, Ellett, A, Borm, K, Flynn, J, Erikstrup, C, Gouillou, M, Gray, LR, Saksena, NK, Wang, B, Purcell, DFJ, Kallestrup, P, Zinyama-Gutsire, RB, Gomo, E, Ullum, H, Ostergaard, L, Lee, B, Ramsland, PA, Churchill, MJ & Gorry, PR 2013, 'Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection', PLOS ONE, vol. 8, no. 6, pp. e65950. https://doi.org/10.1371/journal.pone.0065950

@article{aead5be9c85548e7a58739c449492c64,

title = "Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Na{\"i}ve Subjects with Progressive HIV-1 Subtype C Infection",

abstract = "HIV-1 subtype C (C-HIV) is responsible for most HIV-1 cases worldwide. Although the pathogenesis of C-HIV is thought to predominantly involve CCR5-restricted (R5) strains, we do not have a firm understanding of how frequently CXCR4-using (X4 and R5X4) variants emerge in subjects with progressive C-HIV infection. Nor do we completely understand the molecular determinants of coreceptor switching by C-HIV variants. Here, we characterized a panel of HIV-1 envelope glycoproteins (Envs) (n = 300) cloned sequentially from plasma of 21 antiretroviral therapy (ART)-na{\"i}ve subjects who experienced progression from chronic to advanced stages of C-HIV infection, and show that CXCR4-using C-HIV variants emerged in only one individual. Mutagenesis studies and structural models suggest that the evolution of R5 to X4 variants in this subject principally involved acquisition of an {"}Ile-Gly{"} insertion in the gp120 V3 loop and replacement of the V3 {"}Gly-Pro-Gly{"} crown with a {"}Gly-Arg-Gly{"} motif, but that the accumulation of additional gp120 {"}scaffold{"} mutations was required for these V3 loop changes to confer functional effects. In this context, either of the V3 loop changes could confer possible transitional R5X4 phenotypes, but when present together they completely abolished CCR5 usage and conferred the X4 phenotype. Our results show that the emergence of CXCR4-using strains is rare in this cohort of untreated individuals with advanced C-HIV infection. In the subject where X4 variants did emerge, alterations in the gp120 V3 loop were necessary but not sufficient to confer CXCR4 usage.",

keywords = "Journal Article",

author = "Jakobsen, {Martin R} and Kieran Cashin and Michael Roche and Jasminka Sterjovski and Anne Ellett and Katharina Borm and Jacqueline Flynn and Christian Erikstrup and Maelenn Gouillou and Gray, {Lachlan R} and Saksena, {Nitin K} and Bin Wang and Purcell, {Damian F J} and Per Kallestrup and Zinyama-Gutsire, {Rutendo B} and Exnevia Gomo and Henrik Ullum and Lars Ostergaard and Benhur Lee and Ramsland, {Paul A} and Churchill, {Melissa J} and Gorry, {Paul R}",

year = "2013",

month = jun,

day = "18",

doi = "10.1371/journal.pone.0065950",

language = "English",

volume = "8",

pages = "e65950",

journal = "PLoS Computational Biology",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "6",

}

TY - JOUR

T1 - Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection

AU - Jakobsen, Martin R

AU - Cashin, Kieran

AU - Roche, Michael

AU - Sterjovski, Jasminka

AU - Ellett, Anne

AU - Borm, Katharina

AU - Flynn, Jacqueline

AU - Erikstrup, Christian

AU - Gouillou, Maelenn

AU - Gray, Lachlan R

AU - Saksena, Nitin K

AU - Wang, Bin

AU - Purcell, Damian F J

AU - Kallestrup, Per

AU - Zinyama-Gutsire, Rutendo B

AU - Gomo, Exnevia

AU - Ullum, Henrik

AU - Ostergaard, Lars

AU - Lee, Benhur

AU - Ramsland, Paul A

AU - Churchill, Melissa J

AU - Gorry, Paul R

PY - 2013/6/18

Y1 - 2013/6/18

N2 - HIV-1 subtype C (C-HIV) is responsible for most HIV-1 cases worldwide. Although the pathogenesis of C-HIV is thought to predominantly involve CCR5-restricted (R5) strains, we do not have a firm understanding of how frequently CXCR4-using (X4 and R5X4) variants emerge in subjects with progressive C-HIV infection. Nor do we completely understand the molecular determinants of coreceptor switching by C-HIV variants. Here, we characterized a panel of HIV-1 envelope glycoproteins (Envs) (n = 300) cloned sequentially from plasma of 21 antiretroviral therapy (ART)-naïve subjects who experienced progression from chronic to advanced stages of C-HIV infection, and show that CXCR4-using C-HIV variants emerged in only one individual. Mutagenesis studies and structural models suggest that the evolution of R5 to X4 variants in this subject principally involved acquisition of an "Ile-Gly" insertion in the gp120 V3 loop and replacement of the V3 "Gly-Pro-Gly" crown with a "Gly-Arg-Gly" motif, but that the accumulation of additional gp120 "scaffold" mutations was required for these V3 loop changes to confer functional effects. In this context, either of the V3 loop changes could confer possible transitional R5X4 phenotypes, but when present together they completely abolished CCR5 usage and conferred the X4 phenotype. Our results show that the emergence of CXCR4-using strains is rare in this cohort of untreated individuals with advanced C-HIV infection. In the subject where X4 variants did emerge, alterations in the gp120 V3 loop were necessary but not sufficient to confer CXCR4 usage.

AB - HIV-1 subtype C (C-HIV) is responsible for most HIV-1 cases worldwide. Although the pathogenesis of C-HIV is thought to predominantly involve CCR5-restricted (R5) strains, we do not have a firm understanding of how frequently CXCR4-using (X4 and R5X4) variants emerge in subjects with progressive C-HIV infection. Nor do we completely understand the molecular determinants of coreceptor switching by C-HIV variants. Here, we characterized a panel of HIV-1 envelope glycoproteins (Envs) (n = 300) cloned sequentially from plasma of 21 antiretroviral therapy (ART)-naïve subjects who experienced progression from chronic to advanced stages of C-HIV infection, and show that CXCR4-using C-HIV variants emerged in only one individual. Mutagenesis studies and structural models suggest that the evolution of R5 to X4 variants in this subject principally involved acquisition of an "Ile-Gly" insertion in the gp120 V3 loop and replacement of the V3 "Gly-Pro-Gly" crown with a "Gly-Arg-Gly" motif, but that the accumulation of additional gp120 "scaffold" mutations was required for these V3 loop changes to confer functional effects. In this context, either of the V3 loop changes could confer possible transitional R5X4 phenotypes, but when present together they completely abolished CCR5 usage and conferred the X4 phenotype. Our results show that the emergence of CXCR4-using strains is rare in this cohort of untreated individuals with advanced C-HIV infection. In the subject where X4 variants did emerge, alterations in the gp120 V3 loop were necessary but not sufficient to confer CXCR4 usage.

KW - Journal Article

U2 - 10.1371/journal.pone.0065950

DO - 10.1371/journal.pone.0065950

M3 - Journal article

C2 - 23824043

SN - 1932-6203

VL - 8

SP - e65950

JO - PLoS Computational Biology

JF - PLoS Computational Biology

IS - 6

ER -

Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this